Pain
Conditions
Brief summary
Postoperative analgesia following spine surgery is difficult to manage. Current treatment modalities rely heavily on opioid analgesics with all of the inherent limitations and side effects. While current best practice focuses on a 'multimodal approach' (i.e. using multiple different drugs and techniques to control pain after surgery), there is no consensus regarding which components of this multimodal therapy provide optimal analgesia. This prospective randomized study will enroll patients undergoing elective Lumbar Spinal Fusion Surgery at Zale Lipshy University Hospital. The primary objective is to determine the comparative efficacy of epidural analgesia, as compared with intravenous (IV) patient-controlled analgesia (PCA), on post-operative analgesia.
Detailed description
Study Design: Prospective study of 58 subjects undergoing elective Lumbar Spinal Fusion (1-3 levels- posterior approach) at UTSW Zale Lipshy University Hospital with: 1. Continuous Lumbar Epidural Analgesia (Patient-Controlled Epidural Analgesia- PCEA groups) 2. Intravenous Patient-Controlled Analgesia (IV PCA) Study Interventions - The intervention to be evaluated in this study is epidural analgesia using an infusion of 0.0625% bupivacaine plus fentanyl 2mcg/ml. The epidural infusion will be continued until it is appropriate to transition the patient to a regimen of oral pain medications. Duration of epidural catheter will be 72 hours a postoperatively. For subjects in the IV PCA group, the intervention will include post-operative IV PCA with Hydromorphone. Epidural catheters will be placed by the spine surgeon under direct visualization intra-operatively prior to closing the surgical incision. Intra-operative epidural catheter placement by the spine surgeon will typically be done at the upper end of the dural exposure/laminectomy. Epidurals will be assessed for efficacy/function in the recovery room post-operatively by the APS, and then daily on the floor post-operatively (unless contacted by the floor nurse regarding specific concerns). Visual analog pain scale (VAS) will be used to evaluate degree of pain at 3, 24, 48, and 72 hours after surgery. Additionally, both the IV PCA and the epidural PCEA groups may be given additional rescue pain medications as needed in the recovery room, and these may be continued through the post-operative period on the floor. Total study duration is approximately 50 days, which starts from operating room admission for spinal fusion surgery to the first follow-up visit after discharge.
Interventions
Bupivacaine (0.0625%) will be combined with fentanyl for postoperative epidural analgesia via a lumbar epidural catheter
Hydromorphone will be given continuous infusion for intravenous patient controlled analgesia (syringe 25 mg/50 mL).
Fentanyl (2 mcg/ml) will be given via epidural route together with bupivacaine.
Sponsors
Study design
Eligibility
Inclusion criteria
* Adult subjects aged 18 years or older * Scheduled for elective posterior lumbar spinal fusion surgery between 1 and 3 levels
Exclusion criteria
* Baseline cognitive deficits sufficient to make objective pain self-assessments unreliable in the estimation of the Study Investigators. * Immunocompromised subject * Coagulopathy * Severe liver and renal dysfunction * Preoperative neurological deficits * The dura damage during surgery * Inability to follow directions or comprehend the English language. * Females who are pregnant as determined by positive pregnancy test on or before the day of surgery. * Prisoners. * Patient refusal to provide informed consent. * Allergy to amide local anesthetics (lidocaine, bupivacaine, ropivacaine) or opioid (fentanyl) allergy if patient assigned epidural analgesia. * Hydromorphone allergy if patient assigned IV PCA
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Visual Analog Pain Score (VAS) | VAS score at postoperative 24 hours | Postoperative Visual Analog Pain Score following lumbar fusion surgery. VAS on the scale 0 to 100 (0= no pain, 100= worst pain). |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Patient-Controlled Epidural Analgesia Bupivacaine and fentanyl infusion via Continuous Lumbar Epidural Analgesia during postoperative 72 hours
Bupivacaine: Bupivacaine (0.0625%) will be combined with fentanyl for postoperative epidural analgesia via a lumbar epidural catheter
Fentanyl: Fentanyl (2 mcg/ml) will be given via epidural route together with bupivacaine. | 17 |
| Intravenous Patient-controlled Analgesia Postoperative intravenous patient-controlled analgesia (IV PCA) with Hydromorphone
Hydromorphone: Hydromorphone will be given continuous infusion for intravenous patient controlled analgesia (syringe 25 mg/50 mL). | 18 |
| Total | 35 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | Epidural catheter removal | 1 | 0 |
| Overall Study | Intervention discontinue due to clinical condition | 2 | 2 |
| Overall Study | Intervention not received according to the protocol. | 1 | 1 |
| Overall Study | Physician Decision | 1 | 0 |
| Overall Study | Randomization not applied | 1 | 1 |
| Overall Study | Withdrawal by Subject | 0 | 1 |
Baseline characteristics
| Characteristic | Total | Patient-Controlled Epidural Analgesia | Intravenous Patient-controlled Analgesia |
|---|---|---|---|
| Age, Categorical <=18 years | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical >=65 years | 21 Participants | 12 Participants | 9 Participants |
| Age, Categorical Between 18 and 65 years | 14 Participants | 5 Participants | 9 Participants |
| Age, Continuous | 63.37 years STANDARD_DEVIATION 11.36 | 66.8 years STANDARD_DEVIATION 6 | 60 years STANDARD_DEVIATION 14 |
| Ethnicity (NIH/OMB) Hispanic or Latino | 2 Participants | 1 Participants | 1 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 33 Participants | 16 Participants | 17 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 0 Participants | 0 Participants | 0 Participants |
| Preoperative Pain Score | 37.37 units on a scale (0 to 100) STANDARD_DEVIATION 24.57 | 39.47 units on a scale (0 to 100) STANDARD_DEVIATION 23.09 | 35.38 units on a scale (0 to 100) STANDARD_DEVIATION 26.4 |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Asian | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Black or African American | 4 Participants | 2 Participants | 2 Participants |
| Race (NIH/OMB) More than one race | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 1 Participants | 1 Participants | 0 Participants |
| Race (NIH/OMB) White | 30 Participants | 14 Participants | 16 Participants |
| Sex: Female, Male Female | 26 Participants | 11 Participants | 15 Participants |
| Sex: Female, Male Male | 9 Participants | 6 Participants | 3 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 19 | 0 / 21 |
| other Total, other adverse events | 0 / 19 | 0 / 21 |
| serious Total, serious adverse events | 0 / 19 | 0 / 21 |
Outcome results
Visual Analog Pain Score (VAS)
Postoperative Visual Analog Pain Score following lumbar fusion surgery. VAS on the scale 0 to 100 (0= no pain, 100= worst pain).
Time frame: VAS score at postoperative 24 hours
Population: Spinal fusion surgeries level 1 to 3.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Patient-Controlled Epidural Analgesia | Visual Analog Pain Score (VAS) | 40.23 units on a scale | Standard Deviation 24.69 |
| Intravenous Patient-controlled Analgesia | Visual Analog Pain Score (VAS) | 54.27 units on a scale | Standard Deviation 25.41 |